STAT

OCTOBER 28, 2022

There are increasing signs that flu season is off to a very early start in parts of the United States, with the cumulative hospitalization rate higher than it has been at this point in the fall for more than a decade, the Centers for Disease Control and Prevention reported Friday. In its weekly FluView report , the CDC estimated that there have already been 880,000 influenza illnesses, 6,900 flu hospitalizations, and 360 deaths caused by flu this season, which started at the beginning of October

Hospitals 308

Hospitals 308

PharmaVoice

OCTOBER 25, 2022

The company’s co-founder and head of R&D on how it’s using synthetic mRNA to create “smarter” therapies that could provide cures for cancer and more.

265

265

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins.

Compounding 124

Compounding 124

PhRMA

OCTOBER 27, 2022

PhRMA is proud to announce the release of its first ever chart pack on health equity. This chart pack contains information on health equity in three sections: (1) A Snapshot of Health Disparities in America, (2) Inequities in Access to Screenings and Medicines Allow Health Disparities to Persist, and (3) PhRMA’s Commitment to Building a More Equitable Health Care System for All.

118

118

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 28, 2022

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned. One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT.

Documentation 291

Documentation Drug Development 291

PharmaVoice

OCTOBER 26, 2022

The VP of regulatory affairs and global patient safety explains why her line of work lets her do “a little of everything,” and the company’s plans to score a new approval for its blockbuster drug.

265

265

Pharmaceutical Technology

OCTOBER 25, 2022

Ast ellas Pharma has announced plans to make a strategic investment to back the development of Taysha Gene Therapies’ adeno-associated virus (AAV) development programmes for Rett syndrome and giant axonal neuropathy (GAN). There are options in the future to possibly apply the worldwide research and development (R&D), manufacturing and marketing expertise of Astellas in gene therapy to AAV gene therapy development programmes of Taysha for genetic ailments of the central nervous system (CNS).

105

105

STAT

OCTOBER 26, 2022

Who gets better medical care in the United States: “addicts,” or “people with substance use disorders”? The terms, of course, mean functionally the same thing. But in the field of addiction medicine, the question presents something of a crisis. Even as drugs and alcohol claim 200,000 lives each year, many who seek addiction treatment are greeted by the harsh, stigmatizing labels that many Americans don’t think twice about: Words like addict, alcoholic, junkie,

Labelling 285

Labelling 285

PharmaVoice

OCTOBER 25, 2022

The company's head of U.S. and Canadian operations explains how the company is evolving its game plan after 100 years in the insulin space.

265

265

pharmaphorum

OCTOBER 25, 2022

Novartis has abandoned development of its drug to treat presbyopia, a common age-related loss of near distance vision, after it failed a phase 2b trial. The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

OCTOBER 25, 2022

Millions will be invited to join the programme to ‘prevent, detect and treat’ diseases

134

134

STAT

OCTOBER 25, 2022

As MacArthur Foundation fellow Jennifer Richeson noted in The Atlantic in 2020, Americans love to perpetuate narratives of racial progress , regardless of whether that narrative is aligned with reality. We saw this in a recent New York Times essay that claimed the change in Covid-19 death rates is a laudable example of the U.S. overcoming racial injustice.

Vaccines 280

Vaccines 280

PharmaVoice

OCTOBER 26, 2022

The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.

Drug Development 265

Drug Development 265

pharmaphorum

OCTOBER 26, 2022

Drugmakers Pfizer and Flynn Pharma have formally launched an appeal against a £70 million ($84 million) fine levied by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The two drugmakers were fined in July, after the CMA upheld a preliminary judgment that Pfizer and Flynn had abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to swell from around £2 million a year in 2012 to £50 million the following y

Drug Pricing 103

Drug Pricing 103

European Pharmaceutical Review

OCTOBER 28, 2022

Biotech firm Omega Therapeutics, Inc. revealed the first patient to be dosed with OTX-2002, the first programmable mRNA therapeutic for c-Myc (MYC) oncogene overexpression, which targets cancer cells while sparing healthy cells. OTX-2002 targets c-Myc (MYC), a key oncogene and master transcription factor that regulates cell proliferation, differentiation and apoptosis and plays a major role in over half of all human cancers.

101

101

STAT

OCTOBER 27, 2022

As an oncologist and a leader at a national cancer organization, I’ve watched countless families celebrate the incredible news that their child has defeated a pediatric cancer. But I often don’t have the heart — at least not right away — to tell them what’s coming next: a lifetime of doctor’s visits, health issues, and stress, much of it related to the treatments that were used to ensure their child’s survival.

269

269

PharmaVoice

OCTOBER 27, 2022

Biogen and Eisai's new Alzheimer's drug is wowing investigators, and it might help the companies get past previous failures.

246

246

pharmaphorum

OCTOBER 25, 2022

AstraZeneca’s IL-5 inhibitor Fasenra is already making blockbuster sales from its use in eosinophilic asthma, but the drugmaker’s efforts to expand its label keep running into difficulties. Earlier this year, the FDA rejected AZ’s application for Fasenra (benralizumab) as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) with a request for more data.

Labelling 102

Labelling 102

Pharma Times

OCTOBER 27, 2022

UK only places 11th in terms of total R&D investment as a percentage of GDP

143

143

STAT

OCTOBER 25, 2022

Over the past few weeks, cases of flu have begun to creep up across the U.S., with spikes in the southeast and south central part of the country. Flu hospitalizations are also on the rise. According to the Centers for Disease Control and Prevention’s influenza tracking team, all signs point to an earlier than usual flu season. At the same time, hospitals across the country are filling up with children who’ve contracted RSV — a virus that causes common cold-like symptoms that

Hospitals 258

Hospitals Vaccines 258

PharmaVoice

OCTOBER 28, 2022

Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.

245

245

PhRMA

OCTOBER 26, 2022

A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.

106

106

PioneerRx

OCTOBER 25, 2022

With Halloween slowly — but spookily — creeping its way up to our calendars, it’s a perfect time to explore the more bone-chilling side of the pharmacy industry.

105

105

STAT

OCTOBER 27, 2022

Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, one manufacturer has returned to the market — but is selling its medicine for 10 to 20 times the prices offered by the only other companies with available supplies. Over the past week, Areva Pharmaceuticals began marketing vials of fludarabine at a wholesale price of $2,736, a much steeper cost than the $272 charged for the same dosage by Fresenius Kabi and the $109 price

Dosage 256

Dosage Drug Pricing 256

PharmaVoice

OCTOBER 24, 2022

In a recent study, 50% of healthcare consumers reported that a bad digital experience with their provider ruined the entire experience, while 39% felt that a good digital interaction had a positive influence.

187

187

Pharma Times

OCTOBER 26, 2022

The International AIDS Vaccine Initiative is a global nonprofit scientific research organisation

Vaccines 128

Vaccines 128

Digital Pharmacist

OCTOBER 26, 2022

On October 7 th , 2022 the U.S. Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.

Vaccines 98

Vaccines Hospitals Immunity Immunization 98

STAT

OCTOBER 27, 2022

The crisis of opioid overdose deaths that sparked the multitude of lawsuits leading to a historic settlement continues to rage, with overdose deaths at an all-time high despite heightened national awareness and more resources than ever dedicated to treatment and overdose prevention. The persistence of this crisis underscores the dire need for well-informed and sustainable solutions that work — and funding for them.

252

252

PharmaVoice

OCTOBER 24, 2022

In Amgen's 2022 Biosimilars Trend Report, the company tracks the progress and potential of the copycat drugs as they reach a pivotal moment.

Biosimilars 204

Biosimilars 204

Pharmaceutical Technology

OCTOBER 25, 2022

BioMed X has entered a research partnership with Sanofi to leverage artificial intelligence (AI) for drug development. Under the joint research project, a new research team will be set up at the BioMed X Institute in Heidelberg, Germany. This team will focus on creating a versatile computational platform that can precisely forecast the first-in-class drug candidates’ efficacy in virtual patient groups.

Drug Development 98

Drug Development Diabetes Immunity Immunization 98

Board Vitals - Pharmacist

OCTOBER 23, 2022

Becoming a Family Medicine physician is a goal for thousands of medical students. According to the the American Association of Medical Colleges (AAMC) , Family Medicine is the second most popular medical specialty, and is chosen by approximately 8.5% of first-year medical residents for their residency training. . Like all medical specialties, becoming board certified in family medicine involves careful preparation—including studying for and passing the American Board of Family Medicine (ABFM) Ce

Medical Schools 98

Medical Schools Immunity Immunization 98

STAT

OCTOBER 27, 2022

Flooding, heat waves, wildfires, and other climate-driven weather extremes in recent years have catapulted hospitals into emergency mode and devastated the communities they serve, with Hurricane Ian’s deadly rampage through central Florida only the most recent example.  But while hospitals might seem to be the unwitting victims of climate disasters, the U.S. health care system — and hospitals in particular — shoulder a good deal of the blame.

Hospitals 240

Hospitals 240

PharmaVoice

OCTOBER 24, 2022

Why a ‘very exciting’ trial of the therapy in lupus patients could swing the door open to new studies in autoimmune diseases.

204

204

Pharma Times

OCTOBER 25, 2022

A series of virtual hackathons are open for innovators to create a technology-based dementia tool

127

127

pharmaphorum

OCTOBER 27, 2022

The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle. However, fostering lasting and meaningful partnerships is not a simple task for life science companies.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97